Member Info for Jarv55

Unitedguy of course its a start up no one said it wasn't but that does not mean it can not grow into a decent company. And yes it might take months but most of us are invested here not a day trader like you.

And if you bothered to contact the distrubuters you would also know that your £2 per litre quote is rubbish too would love to know where you got that one from.

UnitedGuy if you had been following intstagram you would know they are selling well. I am expecting another order soon they are flying off the shelves.

DrMhico he is worse than the rampers with his lies. He is here to get your shares he is not having mine. Nano-10 selling well, India progressing with marketing. The masks are being sold on Amazon and through Numed. New products in the pipe line, filter deal with Volz, Citrus trials on going, Nano manufacturing set to increase. NHS event coming up on the 15th September with us sponsoring the event on the gold stand 38. Options given at a higher price Ceo will have skin in the game and an incentive to get the price higher.

United Guy you seem hell bent on not wanting this company to succeed now why is that? You either working for someone who wants in cheaper or you want in cheaper or you have a short running. Today is a good day we have finally got a Ceo lets see what he can do before writing him off before he has even started.

Antony Legge, Chairman of nanosynth, said:

"I am delighted that a CEO of Mark's calibre has agreed to join the Company. His track record in creating shareholder value brings confidence that, together, we can continue to build nanosynth into a major player in the nanotech space."

With this appointment, and as previously envisaged, Antony Legge will revert to his previous role of non-executive Chairman of the Company. Dr Cave's move from a non-executive director to an executive director, taking the role of the Group's Chief Scientific Officer, remains subject to contract and a further announcement will be made once finalised.

nanosynth group plc

("nanosynth" the "Company" or the "Group")

Appointment of CEO and other board changes

The Board of nanosynth is pleased to announce the appointment of Mr. Mark Duffin as Chief Executive Officer of nanosynth, effective immediately.



Mr. Duffin is a qualified engineer with a multi-disciplinary background established over 20 years, including as CEO and board member of various companies in the technology, business services, industrial, manufacturing and consultancy sectors. His experience includes start-up companies, mergers and acquisitions and turnaround propositions.

Mr. Duffin is currently CEO and founder of Angel Share Capital Ltd and prior to that, was CEO of ServicePower Technologies plc (previously AIM listed) where he was responsible for executing a turnaround strategy for the company, resulting in a profit for the first time in fourteen years. Mr. Duffin holds an MBA and a BEng Hons.

Dragline agree the guy is chatting rubbish all day long.

Nano10 is selling well. Expect more orders for them.

United anyone with half a brain knows the Bupa appointment was a pack of lies.

Anyone selling now you really shouldn't be investing news can land anytime. :-)

Happy this morning good option prices over 20 moving day average and he has Aim experience. Has helped over 70 companies lets get this show on the road.

Distribution Agreement in India

The Company is pleased to announce the signing of a distribution agreement between the Company's wholly owned subsidiary, Pharm 2 Farm Ltd ("P2F"), and Vivek Kohli Enterprises OPC Private Ltd ("VKE") for VKE to distribute P2F's anti-viral mask, under the Pro-Larva brand name.

VKE has placed an initial order for 350,000 Pro-Larva masks to be airfreighted direct to their distribution centre in India. The masks will be distributed via well-established retail and commercial medical networks. Part of the proceeds from this order will be invested by P2F into a marketing campaign within India to support VKE and build demand for the Pro-Larva mask, which is expected to then lead to increasing repeat orders.

VKE is based in Uttar Pradesh, India, and is part of the Stag International Group ("Stag"), which was founded in 1922 and has a strong presence within the healthcare sector, amongst others, marketing personal protective equipment under the Pure.All brand (www.stag.global). Stag has recently commissioned the first factory within India to produce oxygen concentrators using unique US technology.

Antony Legge, Executive Chairman of RMS, said: "India represents a significant opportunity for our Pro Larva anti-viral mask and we are pleased to be partnering with Stag Global. Whilst this agreement represents an initial modest number of masks, the Company is in discussions with a number of Indian businesses regarding distribution agreements for the Pro-Lava mask and hopes to be announcing further positive news flow in the near term. This deal will help to strengthen P2F's position as a provider of anti-viral masks within the global healthcare market."

Vivek Kohli, Chief Executive of VKE, commented: "I'm delighted to play a strategic role in the introduction of this cutting-edge British technology, that will keep my fellow country men and women safer. This is an exciting opportunity for a new Anglo-British partnership to do good in India."

Update on new product development

The Company is pleased to announce that the 5-ply version of its Pro-Larva anti-viral mask, developed with Volz Filters UK Ltd ("Volz"), has been approved by the UK's Medicines and Healthcare products Regulatory Agency ("MHRA"). The 5-ply mask has an additional filter layer, produced by Volz, after the hydrophobic outer layer, further strengthening the mask's already excellent bacterial filter efficiency.

The last year has established a close working relationship between Volz and the Company's subsidiary, Pharm 2 Farm Ltd ("P2F"). Not only is Volz manufacturing the existing 4-ply anti-viral masks for P2F, but the two companies have also been working on developing a new anti-viral filter material, as an extension of the work on the anti-viral mask and covered by the same patent. This new material has passed the proof-of-concept stage and Volz and P2F are now looking at how this could be commercialised (for example, in heating, ventilation and air conditioning systems), although this is expected to take several months, with work required on moving from proof-of-concept to large scale production.

Antony Legge, Executive Chairman, said; "Volz have been an excellent partner to Pharm 2 Farm, providing support in a number of areas. We are delighted with the MHRA approval for the 5-ply mask and to be working with Volz on an exciting development of the -virion technology, with the potential to incorporate it into air filters." Nope nothing positive coming at all.

Under the terms of the Hydroponics Agreement, PIC has agreed over the next 12 months to purchase a minimum of 40,000 litres in aggregate, of the eight solutions in the nano.10(-9) range, with an expected revenue for the Group of around GBP80,000. However, this is expected to grow significantly as the market becomes more aware of the benefits of the nano particles in plant nutrient ranges.

Barry Faulkner, director of PIC, said; "We have been working closely with Dr Gareth Cave and his team for several years, constantly developing and improving this nutrient range to be the best it can be. Nanoparticles are going to be revolutionary in fertiliser delivery and we can't wait to bring this fantastic product to the UK and European markets."

Antony Legge, Executive Chairman of RMS, said; "We are delighted to have entered into this agreement with PIC which reflects the excellent demand we perceive for Pharm 2 Farm's high-quality nano particles in the hydroponics sector and also demonstrates the breadth of applications where our nano particles can benefit the end-user. We very much look forward to working with PIC to develop the market opportunities for these high-quality nutrients."

As well as putting in place alternative sub-contracting manufacturing arrangements through Voltz Filters UK Limited, the board has also been working with Lemu in respect of the mask making machine that was installed, but never commissioned, at BioCity. Terms have been agreed, in principle to return the mask making machine to Lemu, further details of which will be announced in due course. In addition, the Company is investigating utilising the cash reserves to improve and increase the nanoparticle production capacity by developing a bespoke system, which has complex engineering challenges. Now think about it what would the reason be for them to expand the nano manufacturing capacity?

I appreciate that shareholders have been keen for news, but much of what has been achieved since the start of the year has had to happen behind the scenes and some remains a work in progress. Even so, I am confident that the Group is in a far better place that it was at the start of this year.

Unitedguy I find it amusing how you keep saying nothing positive is coming out of the company as if you know what is going on behind the scenes. Now unless you are the cleaner in the boardroom I don't know how you can say such things. Quite amusing.

https://twitter.com/rosolanor/status/1432625325574348802

I wish people would stop trying to start false rumours its not on. Wait for the official rns before trying to guess the Ceo.